A fact I recently learnedI recently finished reading a book on automata, and according to that book, Turing machines, lambda calculus, and recursive functions all have the same computational ...

A loss function converts the difference between predictions and targets into a quantity that learning algorithms try to minimize. This guide explains the mechanism, trade-offs, evaluation, and ...

As you most likely know by now, the big AI news this week is the resignation of Anthropic researcher Jacob Coxon, announced via X on 8 September 2026. Coxon’s explanation: Anthropic (and OpenAI) are ...

AI has been touted as a tool to streamline drug R&D, which can cost $2.6 billion and take up to 15 years, according to the Journal of Medicinal Chemistry. But whether AI will actually develop better ...

Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

The article mentions how symbolic recursion can destabilize identity and it’s how the true self emerges but it’s kinda vague on the details or the how and I just want to know how much of this is true?

The word “recursion” is the latest buzzword in AI circles. Two separate startups have taken on the name, and many more have started referencing recursive self-improvement (RSI) in their roadmaps. Like ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...